Publikationen von Matthias L. Schroeter

Liem, F.; Varoquaux, G.; Kynast, J.; Beyer, F.; Kharabian, S.; Huntenburg, J. M.; Lampe, L.; Rahim, M.; Abraham, A.; Craddock, R. C. et al.; Riedel-Heller, S.; Luck, T.; Loeffler, M.; Schroeter, M. L.; Witte, V.; Villringer, A.; Margulies, D. S.: Predicting brain-age from multimodal imaging data captures cognitive impairment. NeuroImage 148, S. 179 - 188 (2017)

Steinacker, P.; Semler, E.; Anderl-Straub, S.; Diehl-Schmid, J.; Schroeter, M. L.; Uttner, I.; Foerstl, H.; Landwehrmeyer, B.; von Arnim, C. A.F.; Kassubek, J. et al.; Oeckl, P.; Huppertz, H.-J.; Fassbender, K.; Fliessbach, K.; Prudlo, J.; Roßmeier, C.; Kornhuber, J.; Schneider , A.; Volk, A. E.; Lauer, M.; Danek, A.; Ludolph, A. C.; Otto, M.: Neurofilament as a blood marker for diagnosis and monitoring of primary progressive aphasias. Neurology 88 (10), S. 961 - 969 (2017)

Bisenius, S.; Mueller, K.; Diehl-Schmid, J.; Fassbender, K.; Grimmer, T.; Jessen, F.; Kassubek, J.; Kornhuber, J.; Landwehrmeyer, B.; Ludolph, A. et al.; Schneider, A.; Anderl-Straub, S.; Stuke, K.; Danek, A.; Otto, M.; Schroeter, M. L.; The FTLDc Study Group: Predicting primary progressive aphasias with support vector machine approaches in structural MRI data. NeuroImage: Clinical 14, S. 334 - 343 (2017)

Meyer, S.; Mueller, K.; Stuke, K.; Bisenius, S.; Diehl-Schmid, J.; Jessen, F.; Kassubek, J.; Kornhuber, J.; Ludolph, A. C.; Prudlo, J. et al.; Schneider, A.; Schümberg, K.; Yakushev, I.; Otto, M.; Schroeter, M. L.; The FTLDc Study Group: Predicting behavioral variant frontotemporal dementia with pattern classification in multi-center structural MRI data. NeuroImage: Clinical 14, S. 656 - 662 (2017)

Schütz, L.; Lobsien, D.; Fritzsch, D.; Tiepolt, S.; Werner, P.; Schroeter, M. L.; Berrouschot, J.; Saur, D.; Hesse, S.; Jochimsen, T. et al.; Rullmann, M.; Sattler, B.; Patt, M.; Gertz, H.-J.; Villringer, A.; Claßen, J.; Hoffmann, K.-T.; Sabri, O.; Barthel, H.: Feasibility and acceptance of simultaneous amyloid PET/MRI. European Journal of Nuclear Medicine and Molecular Imaging 43 (12), S. 2236 - 2243 (2016)

Teipel, S.; Raiser, T.; Riedl, L.; Riederer, I.; Schroeter, M. L.; Bisenius, S.; Schneider, A.; Kornhuber, J.; Fliessbach, K.; Spottke, A. et al.; Grothe, M. J.; Prudlo, J.; Kassubek, J.; Ludolph, A.; Landwehrmeyer, B.; Straub, S.; Otto, M.; Danek, A.; the FTLDc Study Group: Atrophy and structural covariance of the cholinergic basal forebrain in primary progressive aphasia. Cortex 83, S. 124 - 135 (2016)

Bisenius, S.; Neumann, J.; Schroeter, M. L.: Response to the letter on ‘Validating new diagnostic imaging criteria for primary progressive aphasia via anatomical likelihood estimation meta-analyses’. European Journal of Neurology 23 (8), S. e52 - e53 (2016)

Tiepolt, S.; Hesse, S.; Patt, M.; Luthardt, J.; Schroeter, M. L.; Hoffmann, K.-T.; Weise, D.; Gertz, H.-J.; Sabri, O.; Barthel, H.: Early [¹⁸F]florbetaben and [¹¹C]PiB PET images are a surrogate biomarker of neuronal injury in Alzheimer’s disease. European Journal of Nuclear Medicine and Molecular Imaging 43 (9), S. 1700 - 1709 (2016)

Klöppel, S.; Boldt, J.; Sturma, D.; Schroeter, M. L.: Frühdiagnostik neurodegenerativer Erkrankungen - Nur mit umfassender Beratung [Early diagnosis of neurodegenerative diseases – Only after comprehensive counselling]. Deutsches Ärzteblatt 113 (29-30), S. B1161 - B1164 (2016)

Werner, P.; Rullmann, M.; Bresch, A.; Tiepolt, S.; Jochimsen, T.; Lobsien, D.; Schroeter, M. L.; Sabri, O.; Barthel, H.: Impact of attenuation correction on clinical [¹⁸F]FDG brain PET in combined PET/MRI. EJNMMI Research 6, 47 (2016)

Bisenius, S.; Neumann, J.; Schroeter, M. L.: Validating new diagnostic imaging criteria for primary progressive aphasia via anatomical likelihood estimation meta-analyses. European Journal of Neurology 23 (4), S. 704 - 712 (2016)

Kharabian, S.; Arélin, K.; Horstmann, A.; Lampe, L.; Kipping, J.; Luck, T.; Riedel-Heller, S.; Schroeter, M. L.; Stumvoll, M.; Villringer, A. et al.; Witte, V.: Higher body mass index in older adults is associated with lower gray matter volume: Implications for memory performance. Neurobiology of Aging 40, S. 1 - 10 (2016)

Milleit, B.; Smesny, S.; Rothermundt, M.; Preul, C.; Schroeter, M. L.; von Eiff, C.; Ponath, G.; Milleit, C.; Sauer, H.; Gaser, C.: Serum S100B protein is specifically related to white matter changes in schizophrenia. Frontiers in Cellular Neuroscience 10, 33 (2016)

Schümberg, K.; Polyakova, M.; Steiner, J.; Schroeter, M. L.: Serum S100B is related to illness duration and clinical symptoms in schizophrenia: A meta-regression analysis. Frontiers in Cellular Neuroscience 10, 46 (2016)

Mueller, K.; Arélin, K.; Möller, H. E.; Sacher, J.; Kratzsch, J.; Luck, T.; Riedel-Heller, S.; Villringer, A.; Schroeter, M. L.: Serum BDNF correlates with connectivity in the (pre)motor hub in the aging human brain: A resting-state fMRI pilot study. Neurobiology of Aging 38, S. 181 - 187 (2016)

Rullmann, M.; Dukart, J.; Hoffmann, K.-T.; Luthardt, J.; Tiepolt, S.; Patt, M.; Gertz, H.-J.; Schroeter, M. L.; Seibyl, J.; Schulz-Schaeffer, W. J. et al.; Sabri, O.; Barthel, H.: Partial-volume effect correction improves quantitative analysis of ¹⁸F-florbetaben β-amyloid PET scans. Journal of Nuclear Medicine 57 (2), S. 198 - 203 (2016)

Wessel, J. R.; Ullsperger, M.; Obrig, H.; Villringer, A.; Quinque, E. M.; Schroeter, M. L.; Bretschneider, K. J.; Arélin, K.; Roggenhofer, E.; Frisch, S. et al.; Klein, T. A.: Neural synchrony indexes impaired motor slowing after errors and novelty following white matter damage. Neurobiology of Aging 38, S. 205 - 213 (2016)

Bisenius, S.; Trapp, S.; Neumann, J.; Schroeter, M. L.: Identifying neural correlates of visual consciousness with ALE meta-analyses. NeuroImage 122, S. 177 - 187 (2015)

Polyakova, M.; Schroeter, M. L.; Elzinga, B. M.; Holiga, Š.; Schoenknecht, P.; de Kloet, E. R.; Molendijk, M. L.: Brain-derived neurotrophic factor and antidepressive effect of electroconvulsive therapy: Systematic review and meta-analyses of the preclinical and clinical literature. PLoS One 10 (11), e0141564 (2015)

Polyakova, M.; Sander, C.; Arélin, K.; Lampe, L.; Luck, T.; Luppa, M.; Kratzsch, J.; Hoffmann, K.-T.; Riedel-Heller, S.; Villringer, A. et al.; Schoenknecht, P.; Schroeter, M. L.: First evidence for glial pathology in late life minor depression: S100B is increased in males with minor depression. Frontiers in Cellular Neuroscience 9, 406 (2015)